Lv1
68 积分 2025-11-18 加入
A review of clinical pharmacology considerations in antibody-drug conjugates approved by the US Food and Drug Administration between 2000 and 2025
1天前
已关闭
Discovery and Preclinical Evaluation of PBX-7016, a Methylenedioxy-Camptothecin Payload for Antibody-Drug Conjugates with Enhanced Therapeutic Potential
11天前
已完结
Fusion protein linkers: Property, design and functionality
16天前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
16天前
已完结
PCA062, a P-cadherin Targeting Antibody–Drug Conjugate, Displays Potent Antitumor Activity Against P-cadherin–expressing Malignancies
22天前
已完结
Degrader-Drug Conjugate (DDC) Mediated Immunochemotherapy for Tumor Treatment
25天前
已完结
An anti-CD98 antibody displaying pH-dependent Fc-mediated tumour-specific activity against multiple cancers in CD98-humanized mice
1个月前
已完结
The first ADC bearing the ferroptosis inducer RSL3 as a payload with conservation of the fragile electrophilic warhead
1个月前
已完结
Development of a Highly Selective Ferroptosis Inducer Targeting GPX4 with 2-Ethynylthiazole-4-carboxamide as Electrophilic Warhead
1个月前
已完结
Analytical tools for antibody–drug conjugates: From in vitro to in vivo
1个月前
已完结
皖公网安备34019202002308
